Cove Street Capital LLC 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-15 5:07 pm Sale | 2023-08-15 | 13D | Lifecore Biomedical, Inc. LFCR | Cove Street Capital LLC | 1,583,440 5.150% | -791,325 (-33.32%) | Filing |
| 2023-01-12 4:23 pm Purchase | 2023-01-12 | 13D | Lifecore Biomedical, Inc. LFCR | Cove Street Capital LLC | 2,374,765 7.890% | 578,401 (+32.20%) | Filing |
| 2022-02-11 3:36 pm Purchase | 2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | Cove Street Capital LLC | 1,796,364 6.090% | 187,746 (+11.67%) | Filing |
| 2021-03-25 4:27 pm Purchase | 2021-03-25 | 13G | Lifecore Biomedical, Inc. LFCR | Cove Street Capital LLC | 1,608,618 5.490% | 1,608,618 (New Position) | Filing |